Malignant glioma--a nemesis which requires clinical and basic investigation in radiation oncology

Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

DOI:https://doi.org/10.1016/0360-3016(89)90936-X· OSTI ID:5876424

Davis, L W

Malignant gliomas account for 40% of all central nervous system malignancies. These are essentially localized neoplastic tumors that have defied most treatment. In spite of improved techniques, surgery is unlikely to increase survival further since true cancer operations cannot be performed. Radiation therapy has made a significant difference in outcome. Investigation in radiation oncology is essential for further improvement in the treatment of these tumors. The pattern of failure is local tumor recurrence, but the method to overcome this resistance to treatment is not clear. Radiation therapy techniques and inherent radio-resistance have been considered as possible reasons for failure. With newer imaging procedures, the extent of tumor can be more accurately defined allowing improved treatment planning. Identifying an effective treatment program is more difficult. Studies have documented the beneficial effect of radiation therapy, but the optimal dose or fractionation schedule has not been determined. Whereas some studies have reported improved survival using higher radiation doses, others have reported no benefit. More recently, studies of multiple daily fractionation schedules have been conducted using two or three daily fractions. Equally confusing results have been reported. Histologically, these tumors have necrotic areas and may be radioresistant due to hypoxic cells. Treatment methods designed to overcome the radioprotective effect of hypoxia have yielded disappointing results. The addition of hypoxic cell sensitizers has not produced the expected improvement in outcome. Studies using neutron radiation therapy report tumor control but not improved survival. Radiobiologic information is now available which may contribute to our understanding of the response of these tumors to radiation. Further laboratory and clinical investigation is required. 83 references.

• Research Organization: Albert Einstein College of Medicine, Bronx, NY (USA)
• OSTI ID: 5876424
• Journal Information: Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 16:6
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
BRAIN
GLIOMAS
RADIOTHERAPY
FRACTIONATED IRRADIATION
MAN
NEUTRONS
RADIOSENSITIZERS
REVIEWS
SURVIVAL CURVES
ANIMALS
BARYONS
BODY
CENTRAL NERVOUS SYSTEM
DISEASES
DOCUMENT TYPES
DRUGS
ELEMENTARY PARTICLES
FERMIONS
HADRONS
IRRADIATION
MAMMALS
MEDICINE
NEOPLASMS
NERVOUS SYSTEM
NUCLEAR MEDICINE
NUCLEONS
ORGANS
PRIMATES
RADIOLOGY
THERAPY
VERTEBRATES
550603* - Medicine- External Radiation in Therapy- (1980-)